Is 25I-NBOMe legal in Ghana?

Legal status

25I-NBOMe is a controlled substance for medical supply in Ghana, reached through the guideline's definition, and it is not named in the Fifth, Sixth or Seventh Schedule of the Narcotics Control Commission Act 2020 (Act 1019) as read on 3 October 2026. The Food and Drugs Authority's Guidelines for the Sale, Supply and Use of Controlled Substances (FDA/DRI/TSA/GL-SSCS/2020/07, version 01, adopted 8 December 2020, effective 1 January 2021), issued «In pursuance of Section 126 of the Public Health Act, 2012 (ACT 851)», define «"Controlled Substances" or "Controlled drug"» as «a Narcotic drug, Psychotropic substance or Precursor chemical» and a psychotropic substance as «those natural or synthetic substances or any natural material listed in the four Schedules of the 1971 Convention». Section 148(1) of Act 851 says persons in the food and drugs industry «shall comply with the guidelines and codes of practice». The guideline's appendix 9.2.1 says Schedule I «includes the hallucinogen group LSD, DMT, psilocybin etc.», its tables do not name 25I-NBOMe, and its appendix says its list «includes but not limited to» the Green List. The Green List, 36th edition 2025, carries it in Schedule I as PN 008, «2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine». UNODC records that the Commission on Narcotic Drugs, at its 58th session in March 2015, placed «25I-NBOMe» in Schedule I, and that for the substances added to the 1971 Convention «the decision becomes effective at the beginning of November 2015», so it was listed long before the guideline was adopted on 8 December 2020 and its reach does not turn on whether the definition follows later additions. Under Act 1019 the answer is not settled. Fifth Schedule R names amphetamines with their «derivatives, isomers and analogues», and the Act does not define «analogues». 25I-NBOMe is the N-(2-methoxybenzyl) derivative of 2C-I, a phenethylamine without amphetamine's alpha-methyl group, a chemical fact brought from outside the text, so whether it is an amphetamine analogue is a question of construction that no text read answers. The nearest named entry, Seventh Schedule Part 2 item 23, «4-bromo-2,5-dimethoxybenzeneethanamine and any salt, isomer or salt of isomer thereof», is 2C-B, and 25I-NBOMe is not an isomer of it. A web search of ghalii.org, judy.legal, lawsghana.com and dennislawgh.com on 3 October 2026 found no decision applying it either way, which is not proof that none exists. This is stated as the Schedules stand after the Narcotics Control Commission (Amendment) Act, 2023 (Act 1100), which the judy.legal consolidation read on 3 October 2026 records as the Act's only amendment, «Amended by Narcotics Control Commission (Amendment) Act, 2023 (Act 1100 of 2023) on 2 August 2023». The Bill for that Act, read the same day, is «composed of a single clause» and was introduced «to substitute section 43»; the enacted text of Act 1100 was not itself read. The power to move the lists is in section 112: its subsection (1) gave a power to revise the Sixth, Seventh and Eighth Schedules within twelve months of commencement, and its subsection (2)(b) gives a continuing power to make Regulations specifying «the classification of drugs and the appropriate penalties». The only Regulations found under the Act, L.I. 2475 of 2023 on cannabis cultivation, list ninety six regulations and five Schedules of their own on the table of contents read on 3 October 2026 and revise no Schedule of the Act, and this does not rule out a later instrument that was not found.

Consequences if caught

Capital exposure: none. Neither Act 1019 nor the Public Health Act 2012 (Act 851) prints a sentence of death. Two regimes, and which one reaches 25I-NBOMe for a user is not settled. Under the medical supply regime: Act 851's offences attach to a «drug», which section 149 defines to include a substance referred to in a publication named in its Fourth Schedule, which was not read, and a substance «prepared, sold or represented for use» in treating disease or in modifying organic functions, so whether a street sale of 25I-NBOMe is a sale of a drug in that sense is not settled. If it is: Section 118(1) of Act 851 says a person shall not «manufacture, prepare, import, export, distribute, sell, supply or exhibit for sale a drug» that the Authority has not registered, section 122(1) forbids importing a drug without a licence or permit under that Part, and section 129 punishes a contravention of sections 111 to 124 on summary conviction by a fine of not less than seven thousand five hundred and not more than fifteen thousand penalty units or imprisonment of not less than fifteen and not more than twenty five years, or both. Breach of the guideline itself is sanctioned by section 148: subsection (1) says persons in the food and drugs industry «shall comply with the guidelines and codes of practice», subsection (4) makes a person who fails to comply liable to «an administrative penalty of not more than two thousand five hundred penalty units», and subsection (5) makes failure to pay that penalty an offence carrying imprisonment of not more than five years. Section 113(1) also makes it an offence to sell a drug «in contravention of Regulations or Guidelines made under this Part», punishable under section 129, but it sits under the heading «Deception of consumers», and whether it reaches a sale that breaks the guideline's prescription rule without deceiving anyone is not settled. Section 126 itself creates no offence. Section 123(1) reaches possession only of a «counterfeit drug». No provision of Act 851 read for this cell makes possession by a user an offence. If the «analogues» limb of Fifth Schedule R were held to reach 25I-NBOMe, it would be a narcotic drug under Act 1019, and then every Act 1019 offence would attach, including possession for use and purchase for personal use. Its Second Schedule, read in the text layer of the official parliamentary text on 3 October 2026, sets these bands: possession for use under section 37(2)(a), a fine of not less than two hundred and not more than five hundred penalty units, with not more than fifteen months' imprisonment in default; possession for trafficking under section 37(2)(b), importation or exportation under section 36 and prohibited business under section 38, each a fine of not less than ten thousand and not more than twenty five thousand penalty units and imprisonment of not less than ten and not more than twenty five years, with three years in default; and purchase under section 45, which by section 45(2) includes a purchase «for personal use», a fine of not less than two thousand and not more than ten thousand penalty units or imprisonment of not less than four and not more than ten years. Possession for trafficking means a quantity «in excess of a quantity which can reasonably be used by an individual in a day». Section 50 requires life imprisonment where a person found guilty of a narcotic offence has been convicted «on more than one previous occasion» of an importation, exportation, processing, sale, manufacture, distribution, cultivation or supply offence.

If prescribed or medical

No prescription or medical route for 25I-NBOMe was found. The guideline restricts supply of every controlled substance to licensed wholesalers, hospitals and registered pharmacies, and pharmacies may supply «ONLY on receipt of a valid prescription or signed order».

Documentation

Section 118(2) of Act 851 exempts from the registration rule «an import permit issued by the Authority for the importation of any of the articles mentioned in that subsection which is imported for personal use», and section 122(1) says a person without a licence or permit under that Part «shall not import a drug». The permit procedure for a traveller was not read. Section 118 of the Public Health Act 2012 (Act 851) reaches 25I-NBOMe only if it is a drug in the section 149 sense, and no personal import permit route for it was found. Sections 36(1) and 40(1) of Act 1019 require a licence to import a narcotic drug or plant. That would apply to 25I-NBOMe only if Fifth Schedule R were held to reach it.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Ghana’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.